VBI VACCINES INC.

(VBIV)
  Report
Real-time Estimate Cboe BZX  -  10:34 2022-08-10 am EDT
1.050 USD   +5.00%
08/08VBI VACCINES : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K
PU
08/08VBI VACCINES INC/BC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/08Earnings Flash (VBIV) VBI VACCINES Posts Q2 Revenue $346,000
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about VBI VACCINES INC.
08/08VBI VACCINES : Reports Second Quarter 2022 Financial Results and Provides Corporate Update..
PU
08/08Earnings Flash (VBIV) VBI VACCINES Posts Q2 Revenue $346,000
MT
08/08VBI Vaccines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
CI
08/08VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Updat..
BU
08/08NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
08/01NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
07/12VBI VACCINES : Initial Statement of Beneficial Ownership (Form 3)
PU
07/12VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer
BU
07/12VBI Vaccines Inc. Announces Appointment of John Dillman as Chief Commercial Officer
CI
06/28VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult He..
BU
06/28VBI VACCINES : Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hep..
PU
06/28VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for Its 3-Antigen Adult He..
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell 2500 Growth Index
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell Microcap Growth Index
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell 3000E Growth Index
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell Small Cap Comp Growth Index
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell 2000 Growth Index
CI
06/24VBI VACCINES INC.(NASDAQCM : VBIV) dropped from Russell 3000 Growth Index
CI
06/23VBI VACCINES : Announces Results of Annual General Meeting - Form 8-K
PU
06/22VBI Vaccines Announces Results of Annual General Meeting
BU
06/22VBI Vaccines Receives FDA Orphan Drug Designation for Glioblastoma Treatment
MT
06/22VBI VACCINES : Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of..
PU
06/22VBI Vaccines Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment o..
BU
06/22VBI Vaccines Inc. Receives U.S. Food and Drug Administration Orphan Drug Designation fo..
CI
06/21VBI VACCINES INC.(NASDAQCM : VBIV) dropped from S&P Biotechnology Select Industry Index
CI
06/07VBI Vaccines to Participate in the Jefferies Healthcare Conference
BU
06/06VBI Vaccines Says Vaccine Candidate for Brain Tumors Shows Survival Benefit in Expanded..
MT
06/06VBI Vaccines Presents Updated Phase 2a Tumor Response and Overall Survival Data for VBI..
BU
06/06VBI VACCINES : Presents Updated Phase 2a Tumor Response and Overall Survival Data for VBI-..
PU
06/06VBI Vaccines Inc. Announces Updated Phase 2A Tumor Response and Overall Survival Data f..
CI
06/02VBI Vaccines Announces UK MHRA Marketing Authorisation for PreHevbri, a 3-Antigen Adult..
AQ
06/01VBI Says UK Healthcare Regulator Grants Marketing Approval for Hepatitis B Vaccine
MT
06/01VBI VACCINES : Announces UK MHRA Marketing Authorisation for PreHevbri™, a 3-Antigen..
PU
06/01VBI Vaccines Announces UK MHRA Marketing Authorisation for PreHevbri™, a 3-Antige..
BU
06/01VBI Vaccines Inc. Announces UK MHRA Marketing Authorisation for Prehevbri
CI
05/26VBI Vaccines Announces Abstract Accepted for Oral Presentation at EASL 2022
BU
05/20VBI Vaccines Presented Health Economics and Outcomes Research for PreHevbrio at the Int..
AQ
05/19VBI Vaccines Presented Health Economics and Outcomes Research for PreHevbrio™ at ..
BU
05/09VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update
BU
05/09Earnings Flash (VBIV) VBI VACCINES Posts Q1 Revenue $0.1M
MT
05/09VBI Vaccines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri, a 3-A..
AQ
05/02VBI Vaccines' Hepatitis B Vaccine PreHevbri Granted European Marketing Authorization; S..
MT
05/02VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™..
BU
05/02VBI VACCINES : Announces European Commission Marketing Authorisation for PreHevbri™,..
PU
05/02VBI Vaccines Announces European Commission Marketing Authorization for PreHevbri™
CI
04/28VBI Vaccines Announces Data from VBI-1901 in Recurrent Glioblastoma Patients Selected f..
BU
04/28VBI Vaccines Inc. Announces Data from VBI-1901 in Recurrent Glioblastoma Patients Selec..
CI
04/06VBI Vaccines Announces New Data and Progress of VBI-2900, VBI's eVLP Coronavirus Progra..
AQ
04/05VBI Vaccines Announces New Data and Progress of VBI-2900, VBI's eVLP Coronavirus Progra..
BU
04/05VBI VACCINES : Announces New Data and Progress of VBI-2900, VBI's eVLP Coronavirus Program..
PU
04/05VBI Vaccines Inc. Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavi..
CI
03/29VBI Vaccines Says PreHevbrio Now Available in US for Prevention of Hepatitis B
MT
03/29VBI VACCINES : Announces PreHevbrio™ is Now Available in the United States for the P..
PU
03/29VBI VACCINES : Announces PreHevbrio™ is Now Available in the United States for the P..
PU
03/29VBI Vaccines Inc. Announces PreHevbrio Availability in the United States for the Preven..
CI
03/16VBI VACCINES : 32nd Annual Oppenheimer Healthcare Conference
PU
03/15VBI Vaccines to Participate in the 32nd Annual Oppenheimer Healthcare Conference
BU
03/15VBI VACCINES : to Participate in the 32nd Annual Oppenheimer Healthcare Conference - Form ..
PU
03/08Raymond James Adjusts VBI Vaccines Price Target to $6 From $9, Maintains Strong Buy Rat..
MT
03/07VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides ..
BU
03/07VBI VACCINES : Reports Fourth Quarter and Full Year Financial Results for 2021, Provides C..
PU
03/07VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
02/28VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immun..
AQ
02/25VBI Vaccines Receives Positive European Medicines Agency Opinion for Hepatitis B Vaccin..
MT
02/25VBI VACCINES : Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immuni..
PU
02/25VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immun..
BU
02/25VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immun..
CI
02/24VBI Vaccines Announces PreHevbrio Recommended by CDC Advisory Committee on Immunizatio..
AQ
02/23VBI VACCINES : Announces PreHevbrio™ Recommended by CDC Advisory Committee on Immuni..
PU
02/23VBI Vaccines Announces PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] Recommende..
BU
02/23VBI Vaccines Inc. Announces Prehevbrio [Hepatitis B Vaccine (Recombinant)] Recommends b..
CI
01/26VBI VACCINES : to Participate in the B. Riley Securities 2022 Oncology Investor Conference..
PU
01/26VBI Vaccines to Participate in the B. Riley Securities 2022 Oncology Investor Conferenc..
BU
01/05VBI Vaccines Starts Dosing in Second Phase 2 Hepatitis B Virus Trial
MT
1  2  3  4  5  6Next
Upcoming event on VBI VACCINES INC.